ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

ADIL Adial Pharmaceuticals Inc

1,42
0,02 (1,43%)
22 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Adial Pharmaceuticals Inc ADIL NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,02 1,43% 1,42 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,40 1,36 1,44 1,42 1,40
mais cotações »

Notícias Recentes

Data Hora Fonte Título
15/05/202409:30GLOBEAdial Pharmaceuticals Reports First Quarter 2024 Financial..
22/04/202409:30GLOBEAdial Pharmaceuticals Granted Key Patent from the United..
10/04/202409:30GLOBEAdial Pharmaceuticals Announces Peer-Reviewed Publication..
02/04/202409:30GLOBEAdial Pharmaceuticals Reports 2023 Fiscal Year Financial..
01/03/202421:00GLOBEAdial Pharmaceuticals Announces Exercise of Warrants for..
28/02/202411:30GLOBEAdial Pharmaceuticals Awarded New Patent from the United..
13/02/202411:15GLOBEAdial Pharmaceuticals Awarded New Patent Notice of Allowance..
18/01/202410:30GLOBEAdial Announces Appointment of Tony Goodman as Chief..
20/12/202311:00GLOBEAdial Pharmaceuticals Receives Final Reimbursement Payment..
29/11/202318:05GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
14/11/202319:02GLOBEAdial Pharmaceuticals Reports Third Quarter 2023 Financial..
31/10/202309:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
25/10/202309:00GLOBEAddiction Experts Highlight the Need for..
24/10/202317:30GLOBEAdial Pharmaceuticals Announces Closing of $4 Million..
20/10/202309:00GLOBEAdial Pharmaceuticals Announces $4 Million Private Placement..
19/10/202311:30GLOBEAdial Pharmaceuticals Awarded Notice of Allowance for Key..
18/10/202309:00GLOBEAdial Pharmaceuticals Wins Frost & Sullivan's 2023 North..
28/09/202308:00GLOBEAdial Pharmaceuticals to Host a Virtual Key Opinion Leader..
05/09/202309:30GLOBEAdial Pharmaceuticals to Present at the H.C. Wainwright 25th..
28/08/202309:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
23/08/202309:30GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
21/08/202309:30GLOBEAdial Pharmaceuticals Reports Second Quarter 2023 Financial..
04/08/202309:30GLOBEAdial Pharmaceuticals Announces Reverse Stock Split to..
11/07/202309:30GLOBEAdial Provides Business Update Following Favorable Comments..
01/06/202310:00GLOBEAdial Pharmaceuticals to Present at the 2023 Jefferies..